Nel ASA's 40% Monthly Slide Puts All Eyes on July 15 Report as CEO Departure Rattles Investors

Nel ASA faces critical half-year report with stock at €0.20, CEO departed, and technicals near 52-week low. Market demands revenue proof.

The clock is ticking for Nel ASA. With the half-year report due on 15 July 2026, the Norwegian hydrogen specialist is barrelling into a critical disclosure amid a strict quiet period that bans management from investor conversations. The silence comes at a disastrous moment. The stock closed Friday at €0.20, clocking a daily loss of 3.55% and a weekly decline of 8.72%. Over the past month, the equity has been cut by roughly 40%, wiping out any goodwill earned from a modest year-to-date gain of about 6%.

That collapse has a single, sharp trigger. In mid-June, CEO Håkon Volldal announced his resignation, citing a different professional challenge. He remains on the job during his notice period while the board hunts for a successor. The move landed like a bomb in a market already starved for proof that Nel can convert its technology pipeline into real revenue. The Iwatani Corporation settlement—resolving a costly legal dispute in California—offered some relief, but it removed a brake without adding any thrust.

The numbers from the first quarter already told a grim story. Net order intake plunged to 85 million Norwegian kroner, a fraction of the 312 million kroner booked a year earlier. Revenue ticked down slightly. The only real cushion is a cash pile of roughly 1.4 billion kroner, but at the current share price that balance sheet strength is doing little to arrest the slide. Nel’s market capitalisation has shrunk to around €388 million—big enough to matter industrially, small enough to get hammered when trust evaporates.

Technically, the picture is bleak. The stock has sliced clean through the 50-day moving average of €0.27 and now trades below the 200-day average at €0.21, which has flipped into a resistance zone. The 52-week low of €0.17 is now within striking distance. The relative strength index sits near 32, signalling an almost oversold condition, but the monthly volatility of more than 85% warns that cheap-looking shares can stay cheap when the swings are this violent.

All the usual arguments for Nel are still on the table. In May, the company unveiled its new pressurised alkaline electrolyser platform, billed as ready for commercial deployment and designed to simplify renewable hydrogen projects with repeatable, scalable execution rather than bespoke one-offs. The World Economic Forum and the International Energy Agency both see green hydrogen as essential, but both also flag the real bottleneck: not technology, but bankable demand and project financing. High costs and weak revenue structures continue to stall progress.

That disconnect between politics and profit is exactly what the market is punishing. European subsidies, including the latest EU hydrogen auction, help push projects forward, but they do not solve the valuation problem for equipment suppliers. Investors have sat through enough platform launches and roadmaps. They now want to see a chain of confirmed customers, funded projects, and margins that work without handouts. Until Nel provides that evidence, any recovery attempt will be fragile.

The half-year report on 15 July is the next and possibly only catalyst for the foreseeable future. Nel will have to show that its pipeline is turning into binding orders, not just memoranda of understanding. If it fails, the path to last year’s trough near €0.17 becomes a short one. The leadership vacuum makes that task even harder. Volldal’s departure did not change the strategy, but it did something worse: it cracked the confidence that the strategy can be executed.